Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 13.50
-0.10 (-0.74%)
At close: Jul 15, 2025
Indo-Bangla Pharmaceuticals Company Description
Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories.
The company markets its products in various forms, such as tablets, capsules, intravenous fluids, liquids, suppositories, and injectables.
Indo-Bangla Pharmaceuticals Limited was founded in 1954 and is based in Dhaka, Bangladesh.
Indo-Bangla Pharmaceuticals Limited
| Country | Bangladesh |
| Founded | 1954 |
| Industry | Pharmaceutical Preparations |
| Employees | 152 |
| CEO | A. F. M. Huq |
Contact Details
Address: Plot No. #183, Block #B Dhaka, 1229 Bangladesh | |
| Phone | 880 4 316 1028 |
| Website | indo-banglapharma.com |
Stock Details
| Ticker Symbol | IBP |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| A. F. M. Huq | Chief Executive Officer |
| Md. Nuray Siddique | Chief Financial Officer |